About this Journal Submit a Manuscript Table of Contents
Lymphoma
Volume 2012 (2012), Article ID 346084, 15 pages
http://dx.doi.org/10.1155/2012/346084
Review Article

Diagnostic Workup of Small B Cell Lymphomas: A Laboratory Perspective

1Department of Pathology, Professional Pathology Services, 1 Science Court, Suite 200, Columbia, SC 29203, USA
2Departments of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indiana University Health Pathology Laboratory, 350 W. 11th Street IUHPL 5044, Indianapolis, IN 46202, USA

Received 11 August 2012; Accepted 25 September 2012

Academic Editor: Jan Delabie

Copyright © 2012 Kathryn Rizzo and Mehdi Nassiri. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. S. Jaffe, N. L. Harris, H. Stein, and P. G. Isaacson, “Classification of lymphoid neoplasms: the microscope as a tool for disease discovery,” Blood, vol. 112, no. 12, pp. 4384–4399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Swerdlow, E. Campo, J. N. L Harris, et al., The World Health Organization Classification of Hematopoietic and Lymphoid Tissue, IARC, Lyon, France, 4th edition, 2008.
  3. E. S. Jaffe, “The 2008 WHO classification of lymphomas: implications for clinical practice and translational research,” Hematology American Society Hematology Educational Program, pp. 523–531, 2009. View at Scopus
  4. E. D. Hsi, “Pathologic and molecular genetic features of chronic lymphocytic leukemia,” Seminars in Oncology, vol. 39, no. 1, pp. 74–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Rossi, E. Sozzi, A. Puma et al., “The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors,” British Journal of Haematology, vol. 146, no. 1, pp. 64–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Frater, K. F. McCarron, J. P. Hammel et al., “Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically,” American Journal of Clinical Pathology, vol. 116, no. 5, pp. 655–664, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ponzoni, C. Doglioni, and F. Caligaris-Cappio, “Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment,” Seminars in Diagnostic Pathology, vol. 28, no. 2, pp. 161–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Rossi and G. Gaidano, “Richter syndrome: molecular insights and clinical perspectives,” Hematological Oncology, vol. 27, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Döhner, S. Stilgenbauer, A. Benner et al., “Genomic aberrations and survival in chronic lymphocytic leukemia,” New England Journal of Medicine, vol. 343, no. 26 I, pp. 1910–1916, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Dighiero, “Unsolved issues in CLL biology and management,” Leukemia, vol. 17, no. 12, pp. 2385–2391, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Dal-Bo, I. Del Giudice, R. Bomben et al., “B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage,” British Journal of Haematology, vol. 153, no. 1, pp. 3–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Molina, P. Lin, S. H. Swerdlow, and J. R. Cook, “Marginal zone lymphomas with plasmacytic differentiation and related disorders,” American Journal of Clinical Pathology, vol. 136, no. 2, pp. 211–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. K. Müller-Hermelink, “Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas: marginal zone lymphomas,” Human Pathology, vol. 34, no. 4, pp. 336–340, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Zucca, F. Bertoni, A. Stathis, and F. Cavalli, “Marginal zone lymphomas,” Hematology/Oncology Clinics of North America, vol. 22, no. 5, pp. 883–901, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Bende, F. Van Maldegem, and C. J. M. Van Noesel, “Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas,” Haematologica, vol. 94, no. 8, pp. 1109–1123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Kurtin, “Marginal zone B cells, monocytoid B cells, and the follicular microenvironment: determinants of morphologic features in a subset of low-grade B-cell lymphomas,” American Journal of Clinical Pathology, vol. 114, no. 4, pp. 505–508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Bertoni and E. Zucca, “Delving deeper into MALT lymphoma biology,” Journal of Clinical Investigation, vol. 116, no. 1, pp. 22–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. G. Isaacson and M. Q. Du, “MALT lymphoma: from morphology to molecules,” Nature Reviews Cancer, vol. 4, no. 8, pp. 644–653, 2004. View at Scopus
  19. E. S. Jaffe, “Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation,” Journal of the National Cancer Institute, vol. 96, no. 8, pp. 571–573, 2004. View at Scopus
  20. P. G. Isaacson and M. Q. Du, “Gastrointestinal lymphoma: where morphology meets molecular biology,” Journal of Pathology, vol. 205, no. 2, pp. 255–274, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Parsonnet and P. G. Isaacson, “Bacterial Infection and MALT Lymphoma,” New England Journal of Medicine, vol. 350, no. 3, pp. 213–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. J. M. Ferreri, R. Dolcetti, M. Q. Du et al., “Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy,” Annals of Oncology, vol. 19, no. 5, pp. 835–846, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. Ferreri, S. Govi, and E. Pasini, “Chlamydophila Psittaci eradication with Doxycycline as first-fine targeted therapy for ccular adnexae lymphoma: final results of an international Phase II trial,” Journal of Clinical Oncology, vol. 30, no. 24, pp. 2988–2994, 2012.
  24. M. A. Piris, A. Arribas, and M. Mollejo, “Marginal zone lymphoma,” Seminars in Diagnostic Pathology, vol. 28, no. 2, pp. 135–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Dogan and P. G. Isaacson, “Splenic marginal zone lymphoma,” Seminars in Diagnostic Pathology, vol. 20, no. 2, pp. 121–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Ruiz-Ballesteros, M. Mollejo, A. Rodriguez et al., “Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis,” Blood, vol. 106, no. 5, pp. 1831–1838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Lin, T. J. Molina, J. R. Cook, and S. H. Swerdlow, “Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation,” American Journal of Clinical Pathology, vol. 136, no. 2, pp. 195–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Lin, A. Mansoor, C. Bueso-Ramos, S. Hao, R. Lai, and L. J. Medeiros, “Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: clinicopathologic features of 12 cases,” American Journal of Clinical Pathology, vol. 120, no. 2, pp. 246–253, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S. H. Swerdlow and M. E. Williams, “From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades,” Human Pathology, vol. 33, no. 1, pp. 7–20, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Mozos, C. Royo, E. Hartmann et al., “SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype,” Haematologica, vol. 94, no. 11, pp. 1555–1562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Campo, “Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas I: mantle cell lymphoma, follicular lymphoma, and Burkitt's lymphoma,” Human Pathology, vol. 34, no. 4, pp. 330–335, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Leich, G. Ott, and A. Rosenwald, “Pathology, pathogenesis and molecular genetics of follicular NHL,” Best Practice and Research, vol. 24, no. 2, pp. 95–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Klapper, “Pathobiology and diagnosis of follicular lymphoma,” Seminars in Diagnostic Pathology, vol. 28, no. 2, pp. 146–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. J. Bende, L. A. Smit, and C. J. M. van Noesel, “Molecular pathways in follicular lymphoma,” Leukemia, vol. 21, no. 1, pp. 18–29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Leich, I. Salaverria, S. Bea et al., “Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations,” Blood, vol. 114, no. 4, pp. 826–834, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. E. S. Jaffe, P. M. Banks, B. Nathwani, J. Said, and S. H. Swerdlow, “Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. The ad hoc committee on reporting of lymphoid neoplasms,” Human Pathology, vol. 33, no. 11, pp. 1064–1068, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. C. F. Garcia and S. H. Swerdlow, “Best practices in contemporary diagnostic immunohistochemistry panel approach to hematolymphoid proliferations,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 5, pp. 756–765, 2009. View at Scopus
  38. C. R. Taylor, “IHC and the WHO classification of lymphomas: cost effective immunohistochemistry using a deductive reasoning “decision tree” approach,” Applied Immunohistochemistry and Molecular Morphology, vol. 17, no. 5, pp. 366–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. R. Taylor, “The WHO classification of lymphomas: cost-effective immunohistochemistry using a deductive reasoning “decision tree” approach: part II: the decision rree approach: diffuse patterns of proliferation in lymph nodes,” Applied Immunohistochemistry and Molecular Morphology, vol. 17, no. 6, pp. 470–482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. P. S. Lee, D. Beneck, J. Weisberger, and W. Gorczyca, “Coexpression of CD43 by benign B cells in the terminal ileum,” Applied Immunohistochemistry and Molecular Morphology, vol. 13, no. 2, pp. 138–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. H. Swerdlow, “Genetic and molecular genetic studies in the diagnosis of atypical lymphoid hyperplasias versus lymphoma,” Human Pathology, vol. 34, no. 4, pp. 346–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. J. J. M. van Dongen, A. W. Langerak, M. Brüggemann et al., “Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936,” Leukemia, vol. 17, no. 12, pp. 2257–2317, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Bertoni, A. Rinaldi, E. Zucca, and F. Cavalli, “Update on the molecular biology of mantle cell lymphoma,” Hematological Oncology, vol. 24, no. 1, pp. 22–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Ye, A. Dogan, L. Karran et al., “BCL 10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma,” American Journal of Pathology, vol. 157, no. 4, pp. 1147–1154, 2000. View at Scopus
  45. K. A. Rizzo, B. Streubel, S. Pittaluga et al., “Marginal zone lymphomas in children and the young adult population; Characterization of genetic aberrations by FISH and RT-PCR,” Modern Pathology, vol. 23, no. 6, pp. 866–873, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Baró, B. Espinet, M. Salido et al., “FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach,” Histology and histopathology, vol. 24, no. 11, pp. 1399–1404, 2009. View at Scopus
  47. E. Braggio, A. Dogan, J. J. Keats et al., “Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities,” Modern Pathology, vol. 25, no. 5, pp. 651–660, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. S. P. Treon, L. Xu, G. Yang et al., “MYD88 L265P somatic mutation in Waldenström's macroglobulinemia,” New England Journal of Medicine, vol. 367, no. 9, pp. 826–833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Gachard, M. Parrens, I. Soubeyran et al., “IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas,” Leukemia. In press. View at Publisher · View at Google Scholar · View at Scopus
  50. V. Quesada, L. Conde, N. Villamor et al., “Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia,” Nature Genetics, vol. 44, no. 1, pp. 47–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Wang, M. S. Lawrence, Y. Wan et al., “SF3B1 and other novel cancer genes in chronic lymphocytic leukemia,” New England Journal of Medicine, vol. 365, no. 26, pp. 2497–2506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. R. D. Morin, M. Mendez-Lago, A. J. Mungall et al., “Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma,” Nature, vol. 476, no. 7360, pp. 298–303, 2011. View at Publisher · View at Google Scholar · View at Scopus